Lars Tanum

2.4k total citations
77 papers, 1.6k citations indexed

About

Lars Tanum is a scholar working on Psychiatry and Mental health, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Lars Tanum has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 30 papers in Public Health, Environmental and Occupational Health and 24 papers in Epidemiology. Recurrent topics in Lars Tanum's work include Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (22 papers) and Treatment of Major Depression (18 papers). Lars Tanum is often cited by papers focused on Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (22 papers) and Treatment of Major Depression (18 papers). Lars Tanum collaborates with scholars based in Norway, Sweden and Puerto Rico. Lars Tanum's co-authors include Ulrik Fredrik Malt, Kristin Klemmetsby Solli, Jūratė Šaltytė Benth, Arild Opheim, Nikolaj Kunøe, Zill-E-Huma Latif, Helge Refsum, Torsten Gordh, Peter Krajči and Anne‐Li Lind and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Biological Psychiatry.

In The Last Decade

Lars Tanum

73 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Tanum Norway 18 659 373 370 318 192 77 1.6k
Ole Köhler‐Forsberg Denmark 26 899 1.4× 297 0.8× 436 1.2× 190 0.6× 302 1.6× 92 3.6k
Rebecca Anglin Canada 22 292 0.4× 440 1.2× 154 0.4× 215 0.7× 339 1.8× 43 2.1k
Paolo Mannelli United States 28 360 0.5× 579 1.6× 555 1.5× 707 2.2× 251 1.3× 91 2.1k
Fabio Lugoboni Italy 22 307 0.5× 228 0.6× 154 0.4× 532 1.7× 92 0.5× 99 1.4k
Anna Lembke United States 26 476 0.7× 713 1.9× 307 0.8× 435 1.4× 176 0.9× 69 2.6k
Thomas L. Schwartz United States 27 689 1.0× 118 0.3× 476 1.3× 216 0.7× 235 1.2× 79 2.3k
Mong‐Liang Lu Taiwan 30 1.2k 1.8× 144 0.4× 295 0.8× 232 0.7× 547 2.8× 128 2.9k
Robert B. Cutler United States 22 418 0.6× 190 0.5× 833 2.3× 209 0.7× 269 1.4× 45 1.6k
Kathleen Peindl United States 26 504 0.8× 1.2k 3.3× 328 0.9× 311 1.0× 136 0.7× 55 2.1k
J. Douglas Mann United States 22 429 0.7× 223 0.6× 248 0.7× 66 0.2× 320 1.7× 52 1.6k

Countries citing papers authored by Lars Tanum

Since Specialization
Citations

This map shows the geographic impact of Lars Tanum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Tanum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Tanum more than expected).

Fields of papers citing papers by Lars Tanum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Tanum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Tanum. The network helps show where Lars Tanum may publish in the future.

Co-authorship network of co-authors of Lars Tanum

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Tanum. A scholar is included among the top collaborators of Lars Tanum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Tanum. Lars Tanum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solli, Kristin Klemmetsby, et al.. (2025). Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals. Contemporary Clinical Trials. 152. 107861–107861.
2.
Menezes, Joana, Alex Bersellini Farinotti, Emerson Krock, et al.. (2025). Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients. European Journal of Pain. 29(6). e70022–e70022. 1 indexed citations
3.
Weimand, Bente, Jūratė Šaltytė Benth, John‐Kåre Vederhus, et al.. (2025). Changes in quality of life during 52 weeks of extended-release naltrexone treatment, subsequent by a 1-year post-treatment period. Drug and Alcohol Dependence. 276. 112917–112917.
4.
Benth, Jūratė Šaltytė, Kristin Klemmetsby Solli, Jon Mordal, et al.. (2024). Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study. European Addiction Research. 31(1). 1–12. 4 indexed citations
5.
Nordahl, Hans M., et al.. (2023). Adverse childhood experiences and their association with substance use disorders in adulthood: A general population study (Young-HUNT). Addictive Behaviors Reports. 17. 100488–100488. 17 indexed citations
6.
Midgard, Håvard, et al.. (2023). Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial. Clinical Infectious Diseases. 78(3). 582–590. 11 indexed citations
7.
Fadnes, Lars Thore, Jūratė Šaltytė Benth, Kristin Klemmetsby Solli, et al.. (2021). The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse. European Addiction Research. 28(1). 56–67. 5 indexed citations
8.
9.
10.
Just, David, Claudia Fredolini, Björn Gerdle, et al.. (2019). CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Halvorsen, Jan F., et al.. (2017). Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review. Acta Dermato Venereologica. 97(8). 897–905. 31 indexed citations
12.
Bäckryd, Emmanuel, Lars Tanum, Anne‐Li Lind, Anders Larsson, & Torsten Gordh. (2017). Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. Journal of Pain Research. Volume 10. 515–525. 174 indexed citations
13.
Kunøe, Nikolaj, et al.. (2016). Interest in Extended Release Naltrexone among Opioid Users. European Addiction Research. 22(6). 301–305. 6 indexed citations
14.
Kunøe, Nikolaj, et al.. (2016). Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). BMC Pharmacology and Toxicology. 17(1). 18–18. 22 indexed citations
15.
Engedal, Knut, et al.. (2015). Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depression. Journal of Affective Disorders. 185. 67–75. 11 indexed citations
16.
Tanum, Lars, et al.. (2010). Serum Concentrations of Citalopram – Dose-Dependent Variation inR- andS-Enantiomer Ratios. Pharmacopsychiatry. 43(5). 190–193. 9 indexed citations
17.
Andersen, Solveig Norheim, Trine Grønhaug Halvorsen, Stig Pedersen‐Bjergaard, et al.. (2003). Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction. Journal of Pharmaceutical and Biomedical Analysis. 33(2). 263–273. 82 indexed citations
18.
Tanum, Lars & Ulrik Fredrik Malt. (1996). A New Pharmacologic Treatment of Functional Gastrointestinal Disorder: A Double-Blind Placebo-Controlled Study with Mianserin. Scandinavian Journal of Gastroenterology. 31(4). 318–325. 71 indexed citations
19.
Tanum, Lars & Ulrik Fredrik Malt. (1995). Sodium lactate infusion in fibromyalgia patients. Biological Psychiatry. 38(8). 559–561. 7 indexed citations
20.
Tanum, Lars, et al.. (1981). [Home visiting service in Oslo. Who uses it?].. PubMed. 101(5). 343–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ole Köhler‐Forsberg Breakdown of academic impact, for papers by Rebecca Anglin Breakdown of academic impact, for papers by Paolo Mannelli Breakdown of academic impact, for papers by Fabio Lugoboni Breakdown of academic impact, for papers by Anna Lembke Breakdown of academic impact, for papers by Thomas L. Schwartz Breakdown of academic impact, for papers by Mong‐Liang Lu Breakdown of academic impact, for papers by Robert B. Cutler Breakdown of academic impact, for papers by Kathleen Peindl Breakdown of academic impact, for papers by J. Douglas Mann
Rankless by CCL
2026